Keep calm and carry - gov.uk · Keep calm and carry on vaccinating Dear colleagues Many of you will...
14
Issue 306, March 2020 Vaccine update Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected] CONTENTS National Immunisation Network meeting 2020 is cancelled. Shortage of pneumococcal polysaccharide vaccine (PPV23) Advice on how to manage the PPV23 programme Pneumococcal Polysaccharide Vaccine (PPV) Prevenar13 ® Pneumococcal Conjugate Vaccine (PCV13) PCV13 schedule change reminder Vaccines for the 2019/20 children’s flu programme Providing a second dose of flu vaccine after all Fluenz ® Tetra has expired Expiry dates for Fluenz ® Tetra issued in 2019/20 All influenza vaccines for the 2019/20 season Maternal Pertussis programme – Change to dTaP/IPV vaccine Update to Bexsero Patient Information Leaflet MMR vaccine ordering The EU Falsified Medicines Directive (FMD) and Delegated Regulation as applicable to PHE supplied vaccines for the national immunisation programme Early notice: Easter and spring back holiday delivery and order cut-off changes Registering for a new or updating your existing ImmForm vaccine ordering account Keep calm and carry on vaccinating Dear colleagues Many of you will be involved in providing health services to known or suspected cases of COVID-19 infection. Whilst preventing the spread of COVID-19 and caring for those infected is a public health priority, it is very important to maintain good coverage of immunisations, particularly in the childhood programme. This will avoid outbreaks of vaccine-preventable diseases that could increase further the numbers of patients requiring health services. The routine childhood immunisation programme is highly successful in reducing the incidence of serious and sometimes life-threatening diseases such as pneumococcal and meningococcal infections, whooping cough, diphtheria and measles. It remains important to maintain the best possible vaccine uptake to prevent a resurgence of these infections. Providing baby and parents are well and not displaying symptoms of COVID-19 or other infections, routine childhood immunisations should proceed. The six to eight week baby check is not required as part of the assessment for immunisation to commence at eight weeks of age. To that end, we ask that you continue to offer routine vaccinations maintaining the highest uptake possible.
Transcript of Keep calm and carry - gov.uk · Keep calm and carry on vaccinating Dear colleagues Many of you will...
Issue 306, March 2020
Vaccine update
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
CONTENTSNational Immunisation Network meeting 2020 is cancelled.
Shortage of pneumococcal polysaccharide vaccine (PPV23)
Advice on how to manage the PPV23 programme
Pneumococcal Polysaccharide Vaccine (PPV)
Prevenar13® Pneumococcal Conjugate Vaccine (PCV13)
PCV13 schedule change reminder
Vaccines for the 2019/20 children’s flu programme
Providing a second dose of flu vaccine after all Fluenz® Tetra has expired
Expiry dates for Fluenz® Tetra issued in 2019/20
All influenza vaccines for the 2019/20 season
Maternal Pertussis programme – Change to dTaP/IPV vaccine
Update to Bexsero Patient Information Leaflet
MMR vaccine ordering
The EU Falsified Medicines Directive (FMD) and Delegated Regulation as applicable to PHE supplied
vaccines for the national immunisation programme
Early notice: Easter and spring back holiday delivery
and order cut-off changes
Registering for a new or updating your existing ImmForm vaccine ordering account
Keep calm and carry on vaccinatingDear colleaguesMany of you will be involved in providing health services to known or suspected cases of COVID-19 infection. Whilst preventing the spread of COVID-19 and caring for those infected is a public health priority, it is very important to maintain good coverage of immunisations, particularly in the childhood programme. This will avoid outbreaks of vaccine-preventable diseases that could increase further the numbers of patients requiring health services.The routine childhood immunisation programme is highly successful in reducing the incidence of serious and sometimes life-threatening diseases such as pneumococcal and meningococcal infections, whooping cough, diphtheria and measles. It remains important to maintain the best possible vaccine uptake to prevent a resurgence of these infections.
Providing baby and parents are well and not displaying symptoms of COVID-19 or other infections, routine childhood immunisations should proceed. The six to eight week baby check is not required as part of the assessment for immunisation
to commence at eight weeks of age.To that end, we ask that you continue to offer routine vaccinations maintaining the highest uptake possible.
2 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
National Immunisation Network meeting 2020 is cancelled. It is with great regret that we have made the decision not to go ahead with this year’s NIN2020. It is deeply disappointing as we had the strongest agenda with a diverse and critically important range of expert speakers to share with you. We have had to concentrate our efforts on the current COVID-19 situation. Not only are our speakers but also our delegates maybe engaged directly in the coronavirus response so despite hoping we could go
ahead, we now feel that this is not possible. We will be back in 2021 and hope to share our fantastic agenda with you then. We will issue a save the date for you later this year.For information on COVID-19, please visit: www.gov.uk/government/collections/coronavirus-covid-19-list-of-guidance
Shortage of pneumococcal polysaccharide vaccine (PPV23)Supply of PPV23 remains limited; practices should continue to prioritise vaccination according to the recommendations below.PPV23 is recommended for:
• individuals aged from 2 years or over in clinical risk groups• all individuals aged 65 years and over
A single lifetime dose is recommended for most individuals. Five yearly boosters are recommended for asplenic patients and those with chronic kidney disease.
Advice on how to manage the PPV23 programme1. If you are able to procure stock, the priority should be to offer vaccine to those
newly diagnosed with conditions in the high priority group followed by those in moderate priority groups who have never received PPV23 (see the table below). When such individuals are first identified, if no vaccine is available, please ensure that their records are flagged in order to call them for a future appointment. Also ensure that other aspects of management are optimised and in place (for example antibiotic prophylaxis, or booster doses of PCV13) – as advised in relevant guidance, or by the specialist clinician caring for patient.
2. Any PPV23 dose that the surgery is able to access should be offered opportunistically to high and moderate priority groups attending an appointment at the surgery who have never received PPV23 and are due this vaccine.
3. PPV23 vaccination for lower priority groups (including healthy individuals aged 65 years and over) and booster doses for asplenics, those with splenic dysfunction and chronic kidney disease are less urgent and can be planned when sufficient stock is available.
National stocks of PCV13 (Prevenar13), or separately procured PCV10 (Synflorix), should not be used in place of PPV23 because herd protection from the childhood PCV13 programme has reduced pneumococcal disease due to these serotypes across all ages, including the elderly. PPV23 helps provide additional protection against serotypes that are not covered by PCV13 or PCV10.
3 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Clinical risk group Examples (decision based on clinical judgement)
High priority
Asplenia or dysfunction of the spleen
This also includes conditions such as homozygous sickle cell disease and coeliac syndrome that may lead to splenic dysfunction.
Immunosuppression Due to disease or treatment, including patients undergoing chemotherapy leading to immunosuppression, bone marrow transplant, asplenia or splenic dysfunction, HIV infection at all stages, multiple myeloma or genetic disorders affecting the immune system (e.g. IRAK-4, NEMO, complement deficiency) Individuals on or likely to be on systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg or more per day (any age), or for children under 20kg, a dose of 1mg or more per kg per day.
Individuals with cerebrospinal fluid leaks
It is important that immunisation does not delay the cochlear implantation.
Moderate priority
Chronic respiratory disease
This includes chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema; and such conditions as bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD). Children with respiratory conditions caused by aspiration, or a neurological disease (e.g. cerebral palsy) with a risk of aspiration. Asthma is not an indication, unless so severe as to require continuous or frequently repeated use of systemic steroids (as defined in Immunosuppression below).
Chronic heart disease This includes those requiring regular medication and/or follow-up for ischaemic heart disease, congenital heart disease, hypertension with cardiac complications, and chronic heart failure.
Chronic kidney disease Nephrotic syndrome, chronic kidney disease at stages 4 and 5 and those on kidney dialysis or with kidney transplantation.
Chronic liver disease This includes cirrhosis, biliary atresia and chronic hepatitis.
Diabetes Diabetes mellitus requiring insulin or oral hypoglycaemic drugs. This does not include diabetes that is diet controlled.
Low priority
Healthy over 65s
Table: Priority groups for Pneumococcal polysaccharide 23-valent vaccine (PPV23)
4 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Pneumococcal Polysaccharide Vaccine (PPV)
Image shows PNEUMOVAX® 23 prefilled syringe presentation (PFS) of PPVMSD is transitioning to prefilled syringe presentation (PFS) of PPV under the brand name PNEUMOVAX® 23 which will replace all future supply of vials from May 2020. Vials will continue to be available intermittently until May 2020. A combination of growing global demand for pneumococcal polysaccharide vaccines, alongside manufacturing constraints, have led to regular interruptions in supply of PPV to the UK since 2017. The introduction of a PFS presentation of PPV is intended to support the continuity of supply and to help address public health need. Pneumovax® 23 in the PFS presentation can be ordered in the same way as the PPV in vials; through MSD’s distribution partner AAH online at www.aah.co.uk or by phone on 0344 561 8899. Customers need an AAH account to place an order.For more information about the vaccine, please refer to the Summary of Product Characteristics (SmPC).
5 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Prevenar13® Pneumococcal Conjugate Vaccine (PCV13) Some patients in high risk groups such as those with asplenia, splenic dysfunction, complement disorder or severe immunocompromise, may require extra doses of PCV13 in addition to those that may already have been administered as part of the routine childhood immunisation programme. Further detail on those in these risk groups who may require PCV13 is available in chapter 25 of the Green Book: www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25Prevenar13® for use in risk groups outside of the national programme is supplied directly from Pfizer (single dose packs of Prevenar13®). Due to a temporary gap in Pfizer’s supply chain, for a limited time Prevenar13® from central stock can be used to cover risk groups outside of the national programme.
PCV13 schedule change reminder As published in issue 303 (Dec 2019), the PCV13 routine immunisation schedule changed on the 1 January 2020. The change means that babies born on or after 1 January 2020 will have one priming dose of PCV13 at the age of 12 weeks, followed by a booster dose at the age 12 months. Babies born on or before the 31 December 2019 will continue to be offered two priming doses at the age of 8 and 16 weeks, followed by a booster dose at the age 12 months. Further information is available at weblink 1. Please ensure that you keep the change in schedule in mind when ordering Prevenar13 from ImmForm and do not order too much. We recommend that customers hold a maximum of 2-4 weeks stock to minimise the potential for wastage.
Vaccine supply Routine vaccination programmeVaccines for the 2019/20 children’s flu programmeOrdering for Fluenz® Tetra is now closed.The injectable vaccine (Quadrivalent Influenza Vaccine (split virion, inactivated)) remains available to order.
Providing a second dose of flu vaccine after all Fluenz® Tetra has expired If you still need to give a second dose of flu vaccine four weeks after the first dose (for example, for children in clinical risk groups aged two to under nine years who have not received influenza vaccine before), then it is safe and effective to give inactivated vaccine as a second dose where Fluenz® Tetra is no longer available.
6 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Expiry dates for Fluenz® Tetra issued in 2019/20 Batch numbers and associated expiry dates of Fluenz® Tetra for all batches issued this season are set out in the table below. Batches that have already expired are marked in red.Please ensure that the expiry date is always checked before use and that expired stock is disposed of in line with local policies. Any disposed stock should be recorded through the ImmForm stock incident page at weblink 2. Batch Expiry date in 2020 LJ2149 08-Jan LJ2168 09-Jan LJ2169 10-Jan LJ2334 16-Jan LJ2515 27-Jan LK2526 06-Feb LK2527 10-Feb LK2979 13-Feb LK2980 20-Feb LK2981 27-Feb LK2982 02-Mar LL2196 05-Mar LL2197 12-Mar LL2198 16-Mar LL2199 20-Mar LL2567 26-Mar LM3089 31-Mar LL2570 01-Apr
All influenza vaccines for the 2019/20 seasonInformation on all influenza vaccines marketed in the UK for the 2019/20 season are available at weblink 3. Please refer to the flu letter (see weblink 4) for information on which vaccines are eligible for reimbursement in the 2019/20 season.
7 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Maternal Pertussis programme – Change to dTaP/IPV vaccineThe maternal pertussis immunisation programme commenced in October 2012, initially using Repevax® vaccine (dTaP/IPV). From July 2014, Boostrix®-IPV (dTaP/IPV) has been supplied. Repevax® is now available to order through ImmForm for use in the maternal pertussis immunisation programme instead of Boostrix®-IPV. This is a temporary change and it is anticipated that supplies will revert back to Boostrix®-IPV in autumn 2020. This change is necessary as PHE is running down all stock of Repevax® before the introduction of Boostrix®-IPV across both the maternal pertussis and the pre-school booster programmes. There is no other change to the maternal pertussis immunisation programme, further details about this programme can be found in chapter 24 of the Green Book at weblink 5.
Update to Bexsero Patient Information Leaflet Every pack of Bexsero (Meningitis B vaccine; 10 doses) is supplied with a pad of ten Patient Information Leaflets (PILs), as well as there being a single PIL inside each Bexsero pack. Since late-September 2019, an updated version of the PIL pad has been distributed with Bexsero orders. Please dispose of the single PIL from inside the pack, as it will be out-of-date. We will advise further when the PIL supplied in the pack is in line with the PIL pad.
MMR vaccine ordering There are currently two different vaccines available to order for the MMR programme, MMRvaxPRO® and Priorix®. Orders for Priorix® are capped at 10 packs per order per week for accounts in England and Wales. Controls are also in place for Scottish customers. This is needed to rebalance central supplies. The alternative MMR vaccine, MMRvaxPRO®, remains available to order without restriction. If you specifically require additional Priorix® stock, for example because you serve communities that do not accept vaccines that contain porcine gelatine then please contact the ImmForm Helpdesk for assistance at [email protected] or 0207 183 8580.
The EU Falsified Medicines Directive (FMD) and Delegated Regulation as applicable to PHE supplied vaccines for the national immunisation programme Full information on FMD as it applies to centrally supplied vaccines for the National Immunisation Programme can be found in the April 2019 edition of Vaccine update at weblink 6.ImmForm vaccines in FMD-compliant packs (i.e. subject to the requirements of the Delegated Regulation) are being distributed for all centrally-supplied products (see table below). We would encourage all of our customers to visit the GOV.UK page on FMD at weblink 7 and spend some time becoming familiar with the content and links to various other guidance documents on the implementation of the legislation.
8 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Please note that the barcode on Rotarix batch AROLC284AA (exp. 31/05/2021) is non-serialised and therefore cannot be verified or decommissioned.If you have identified yourself to PHE as being exempt from decommissioning under Article 23 of the Delegated Regulation and this has been agreed, then you will be supplied with decommissioned vaccine.Please see our guidance for more information on the roles and responsibilities in relation to FMD and the Delegated Regulation, regarding vaccines and other medicines centrally supplied by PHE to the NHS and other customers. This document is accessible via GOV.UK at weblink 8.
Product Brand name FMD-compliant packs will be issued which require verification and
decommissioningPneumococcal conjugate vaccine (PCV) Prevenar13 Live
DTaP/IPV vaccine for pregnant women Boostrix-IPV Live
Meningococcal Group ACWY vaccine Nimenrix Live
Measles-Mumps-Rubella (MMR) vaccine MMR VaxPRO Live
DTaP/IPV/Hib/HepB vaccine Infanrix Hexa Live
Tuberculosis vaccine (BCG) BCG Vaccine AJV Live
Meningococcal Group B vaccine Bexsero Live
Shingles (Herpes zoster) vaccine Zostavax Live
Hib/MenC vaccine Menitorix Live
Measles-Mumps-Rubella (MMR) vaccine Priorix Live
Rotavirus vaccine Rotarix Live
Human papillomavirus (HPV) vaccine Gardasil Live
DTaP/IPV vaccine for infants Repevax Live
Td/IPV vaccine Revaxis Live
LAIV Fluenz Tetra Live
Quadrivalent inactivated flu vaccine (QIVe)
Quadrivalent Influenza Vaccine (split virion,
inactivated) Live
Purified protein derivative (Mantoux test) Tuberculin PPD-2TU All stock will be in non-FMD packs
(as it is unlicensed in UK)
9 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Early notice: Easter and spring back holiday delivery and order cut-off changes Due to the Easter Holidays, there will not be any deliveries or order processing by Movianto UK on Friday 10 April 2020 or Monday 13 April 2020. For all Easter and spring bank holidays, order cut-offs will be earlier for some customers with delivery days falling after the bank holidays, to allow enough time for order processing. Please see the tables below for revised order cut-off and delivery dates in bold. Customers are reminded to be prepared for the break in deliveries and to order accordingly. Please make sure you have enough room in your fridge for any additional vaccine you wish to stock over this holiday period. Out of Schedule deliveries cannot be arranged for failure to place orders in good time.
Usual order cut-off day (by 11.55am)
Easter Holiday order cut-off dates (by 11.55 am; revisions are in bold)
Delivery Date
Wednesday Wednesday 1 April 2020 Friday 3 April 2020
Thursday Thursday 2 April 2020 Monday 6 April 2020
Friday Friday 3 April 2020 Tuesday 7 April 2020
Monday Monday 6 April 2020 Wednesday 8 April 2020
Tuesday Tuesday 7 April 2020 Thursday 9 April 2020
Wednesday Not applicable No deliveries – Good Friday, 10 April 2020
Thursday Not applicable No deliveries – Easter Monday, 13 April 2020
Friday Wednesday 8 April 2020 Tuesday 14 April 2020
Monday Thursday 9 April 2020 Wednesday 15 April 2020
Tuesday Tuesday 14 April 2020 Thursday 16 April 2020
Wednesday Wednesday 15 April 2020 Friday 17 April 2020
Thursday Thursday 16 April 2020 Monday 20 April 2020
10 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
For the Early May Bank Holiday, there will not be any deliveries or order processing by Movianto UK on Friday 8 May 2020. The following changes apply:
Usual order cut-off day (by 11.55am)
Easter Holiday order cut-off dates (by 11.55 am; revisions are in bold)
Delivery Date
Wednesday Wednesday 29 April 2020 Friday 1 May 2020Thursday Thursday 30 April 2020 Monday 4 May 2020Friday Friday 1 May 2020 Tuesday 5 May 2020Monday Monday 4 May 2020 Wednesday 6 May 2020Tuesday Tuesday 5 May 2020 Thursday 7 May 2020
Wednesday Not applicable No deliveries – Early May Bank Holiday, Friday 8 May 2020
Thursday Wednesday 6 May 2020 Monday 11 May 2020Friday Thursday 7 May 2020 Tuesday 12 May 2020Monday Monday 11 May 2020 Wednesday 13 May 2020Tuesday Tuesday 12 May 2020 Thursday 14 May 2020Wednesday Wednesday 13 May 2020 Friday 15 May 2020Thursday Thursday 14 May 2020 Monday 18 May 2020
Usual order cut-off day (by 11.55am)
Easter Holiday order cut-off dates (by 11.55 am; revisions are in bold)
Delivery Date
Thursday Thursday 14 May 2020 Monday 18 May 2020Friday Friday 15 May 2020 Tuesday 19 May 2020Monday Monday 18 May 2020 Wednesday 20 May 2020Tuesday Tuesday 19 May 2020 Thursday 21 May 2020Wednesday Wednesday 20 May 2020 Friday 22 May 2020
Thursday Not applicable No deliveries – Spring Bank Holiday Monday, 25 May 2020
Friday Thursday 21 May 2020 Tuesday 26 May 2020Monday Friday 22 May 2020 Wednesday 27 May 2020Tuesday Tuesday 26 May 2020 Thursday 28 May 2020Wednesday Wednesday 27 May 2020 Friday 29 May 2020Thursday Thursday 28 May 2020 Monday 1 June 2020
For the late Spring May Bank Holiday, there will not be any deliveries or order processing by Movianto UK on Monday 25 May 2020. The following changes apply:
11 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Registering for a new or updating your existing ImmForm vaccine ordering accountWhen you register for or update an existing ImmForm account, Public Health England as a wholesaler of vaccines need to verify the requesting customer.Please ensure you have your professional regulatory body registration number or Wholesale Dealers Licence and an organisation code which can be verified when requesting updates or requesting a new vaccine ordering account.For more information please see the ImmForm Helpsheet – How to register at weblink 9.
Vaccine supply Non-routine vaccination programmeHEPATITIS A VACCINEAdult
• GSK: Havrix Adult PFS singles and packs of 10 are available• Sanofi Pasteur: Limited supplies of Avaxim PFS singles are available• Sanofi Pasteur: Avaxim PFS packs of 10 are available• MSD: VAQTA Adult is available
Paediatric• GSK: Havrix Paedatric PFS singles and packs of 10 are available• MSD: VAQTA Paediatric is available
HEPATITIS B VACCINEAdult
• GSK: Engerix B PFS singles and packs of 10 are available• GSK: Engerix B vials singles are available• GSK: Engerix B vials packs of 10 are unavailable• GSK: Fendrix is available• MSD: HBVAXPRO 10 µg is unavailable until further notice• MSD: HBVAXPRO 40 µg is unavailable until further notice
Paediatric• GSK: Engerix B Paediatric singles are available• MSD: HBVAXPRO 5µg are available
12 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
COMBINED HEPATITIS A & B VACCINE• GSK: Limited supplies of Twinrix Adult singles and packs of 10 are available • GSK: Twinrix Paediatric is available• GSK: Ambirix is available
COMBINED HEPATITIS A & TYPHOID VACCINE• Sanofi Pasteur: Viatim is available
TYPHOID VACCINE• Sanofi Pasteur: Limited supplies of Typhim are available. Typhim will be out
of stock from early April until early June 2020• Emergent: Vivotif is available
RABIES VACCINE• GSK; Rabipur is currently available• Sanofi Pasteur: Rabies BP is currently out of stock. An alternative vaccine
is available, please contact Sanofi Pasteur directly for more information
Pneumococcal Polysaccharide Vaccine (PPV)• MSD: Limited supplies of Pneumococcal Polysaccharide Vaccine vials are
available. (Please see page 12 of the Bug Special Vaccine Update issue 300, October 2019 for further information)
• MSD: Supplies of PNEUMOVAX 23 PFS are currently unavailable. Resupply is expected in May 2020
Pneumococcal polysaccharide conjugate Vaccine (PCV)• Pfizer: Prevenar 13 is unavailable. Resupply date to be confirmed. Supplies
for the national immunisation programme are unaffected
VARICELLA ZOSTER VACCINE• GSK: VARILRIX is currently available• MSD: VARIVAX is currently available• MSD: Supplies of ZOSTAVAX are currently unavailable. Resupply is
expected Q2 2020. Supplies for the national immunisation programme are unaffected
DIPHTHERIA, TETANUS AND POLIOMYELITIS (inactivated) VACCINE
• Sanofi Pasteur: Revaxis is available
https://www.gov.uk/government/publications/vaccine-update-issue-300-october-2019-bug-special-edition
13 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
DIPHTHERIA, TETANUS, PERTUSSIS (acellular) AND POLIOMYELITIS (inactivated) VACCINE
• GSK: Limited supply of Boostrix-IPV is currently available
MMR • MSD: Limited supply of MMRvaxPro is currently available. Resupply
expected end of March 2020. Supplies for the national immunisation programme are unaffected
• GSK: Priorix is currently available
MENINGITIS ACWY VACCINE• GSK: Menveo is available• Pfizer: Nimenrix is currently available
YELLOW FEVER• Sanofi Pasteur: Stamaril is available
HUMAN PAPILLOMAVIRUS VACCINE• MSD: Limited supply of GARDASIL is available. Supplies for
the national immunisation programme are unaffected• MSD: Gardasil 9 is currently available• GSK: Cervarix is currently available
CHOLERA VACCINE• Valneva: Dukoral is available
JAPANESE ENCEPHALYTIS VACCINE• Valneva: Ixiaro is available
14 Vaccine update: Issue 306, March 2020
Subscribe to Vaccine update here. Order immunisation publications here. For centrally-supplied vaccine enquiries, email: [email protected]
Weblinksweblink 1 https://www.gov.uk/government/collections/pneumococcal-
vaccination-programme
weblink 2 https://portal.immform.dh.gov.uk/VaccineSupply/VaccineSupply/Stock-Incident/Add-Stock-incident.aspx
weblink 3 https://www.gov.uk/government/publications/influenza-vaccine-ovalbumin-content
weblink 4 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/788903/Annual_national_flu_programme_2019_to_2020_.pdf
weblink 5 https://www.gov.uk/government/publications/pertussis-the-green-book-chapter-24
weblink 6 https://www.gov.uk/government/publications/vaccine-update-issue-293-april-2019
weblink 7 https://www.gov.uk/government/publications/fmd-guidance-for-recipients-of-phe-supplied-vaccines
weblink 8 https://www.gov.uk/government/publications/fmd-guidance-for-recipients-of-phe-supplied-vaccines
weblink 9 https://portal.immform.dh.gov.uk/Help-Guides.aspx
© Crown copyright 2020 – PHE Publications Gateway Number: 2019263
